MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 20 - per page Previous page
Order by
New surrogate biomarker to monitor the progression of HIV infection and other conditions and diseases associated with immune system activation More
An imaging agent specific for colonic polyps that overexpress glycoprotein alpha-L-fucose containing mucins More
A level set based method to determine, from a CT colonography (CTC) scan, the location of the colon serosal tissue boundary: After determining this location, the algorithm segments the entire colon wall at subvoxel accurate precision. More
SELDI-TOF based serum marker protein profiling enables minimally invasive detection of colon cancer with 96.7 percent sensitivity and 100 percent specificity More
This invention is based on the identification of a new splice variant of a gene that appears to exist specifically in HNPCC. More
A pharmacogenetic method to identify candidates who are most likely to benefit from treatment with statins to reduce cancer risk, and consequently minimizing any unnecessary cost and side effects in individuals who do not benefit. More
Using this technology, it will be possible to create high quality images for viewing the colon surface in 3D with reduced false positives in the medium-sized range for colon polyps. More
Platforms for the design of drug delivery systems for colon cancer and other diseases More
A non-invasive and robust hypermethylation assay for early diagnosis, prognosis and monitoring of colorectal cancer. The preliminary results are very encouraging indicating a sensitivity and specificity of more than 90% More
Novel non-natural sphingolipid analogs which have shown better therapeutic activity, particularly anticancer activity, in comparison to cis-Pt, in various cancer cell lines such as colon, lung, and ovarian cancer. More
Displaying 11..20 of 20 - per page Previous page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us